IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

LEIGHANNA OUNANIAN

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Gerontology

NPI
1699253633
CMS profile
11249734
Location
PLANO, TX

General Payments · PY2021–2024

$6,447.14

  • Reported across 162 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$3,314.11

68 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Gerontology TX All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $1,760.00 2
Food and Beverage $1,470.78 65
Long term medical supply or device loan $83.33 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Incyte Corporation $1,465.18 4
Stemline Therapeutics Inc. $534.05 5
NOVARTIS PHARMACEUTICALS CORPORATION $310.19 17
E.R. Squibb & Sons, L.L.C. $208.94 9
Acerta Pharma LLC $166.58 3
PFIZER INC. $110.38 4
Daiichi Sankyo Inc. $79.73 3
Merck Sharp & Dohme Corporation $72.62 4
Janssen Biotech, Inc. $47.12 3
Mirati Therapeutics, Inc. $38.69 2
Karyopharm Therapeutics Inc. $38.67 2
ABBVIE INC. $27.29 1
Adaptive Biotechnologies Corporation $24.25 1
EMD Serono, Inc. $23.47 1
Genmab U.S., Inc. $21.84 1
Lilly USA, LLC $21.77 1
Blueprint Medicines Corporation $20.92 1
Regeneron Healthcare Solutions, Inc. $20.32 1
Deciphera Pharmaceuticals Inc. $19.04 1
MENARINI SILICON BIOSYSTEMS, INC. $17.14 1
Takeda Pharmaceuticals U.S.A., Inc. $16.67 1
SECURA BIO, INC. $14.79 1
GENZYME CORPORATION $14.46 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $782.32 8
PY2022 $1,077.38 39
PY2023 $1,273.33 47
PY2024 $3,314.11 68

Payment records · PY2024 (68)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $27.29 12/06/2024 Food and Beverage Undisputed 01/23/2026 1107773486 CMS
Adaptive Biotechnologies Corporation $24.25 07/15/2024 Food and Beverage Undisputed 01/23/2026 1150266843 CMS
AstraZeneca Pharmaceuticals LP $19.20 01/12/2024 Food and Beverage Undisputed 01/23/2026 1104395157 CMS
AstraZeneca Pharmaceuticals LP $23.68 04/15/2024 Food and Beverage Undisputed 01/23/2026 1104348566 CMS
AstraZeneca Pharmaceuticals LP $123.70 06/27/2024 Food and Beverage Undisputed 01/23/2026 1105769826 CMS
Blueprint Medicines Corporation $20.92 05/01/2024 Food and Beverage Undisputed 01/23/2026 1147450368 CMS
Daiichi Sankyo Inc. $26.70 08/07/2024 Food and Beverage Undisputed 01/23/2026 1089465228 CMS
Daiichi Sankyo Inc. $26.28 08/20/2024 Food and Beverage Undisputed 01/23/2026 1089465226 CMS
Daiichi Sankyo Inc. $26.75 10/23/2024 Food and Beverage Undisputed 01/23/2026 1089465224 CMS
Deciphera Pharmaceuticals Inc. $19.04 06/12/2024 Food and Beverage Undisputed 01/23/2026 1145877801 CMS
E.R. Squibb & Sons, L.L.C. $16.83 01/19/2024 Food and Beverage Undisputed 01/23/2026 1101584747 CMS
E.R. Squibb & Sons, L.L.C. $54.03 03/28/2024 Food and Beverage Undisputed 01/23/2026 1101584869 CMS
E.R. Squibb & Sons, L.L.C. $18.98 05/22/2024 Food and Beverage Undisputed 01/23/2026 1101584822 CMS
E.R. Squibb & Sons, L.L.C. $17.81 06/25/2024 Food and Beverage Undisputed 01/23/2026 1101584832 CMS
E.R. Squibb & Sons, L.L.C. $17.70 07/12/2024 Food and Beverage Undisputed 01/23/2026 1101584839 CMS
E.R. Squibb & Sons, L.L.C. $17.84 07/31/2024 Food and Beverage Undisputed 01/23/2026 1101584850 CMS
E.R. Squibb & Sons, L.L.C. $16.96 08/30/2024 Food and Beverage Undisputed 01/23/2026 1101584866 CMS
E.R. Squibb & Sons, L.L.C. $28.86 10/14/2024 Food and Beverage Undisputed 01/23/2026 1101584895 CMS
E.R. Squibb & Sons, L.L.C. $19.93 11/20/2024 Food and Beverage Undisputed 01/23/2026 1101584940 CMS
EMD Serono, Inc. $23.47 04/05/2024 Food and Beverage Undisputed 01/23/2026 1120227440 CMS
Genmab U.S., Inc. $21.84 09/25/2024 Food and Beverage Undisputed 01/23/2026 1126837504 CMS
GENZYME CORPORATION $14.46 05/06/2024 Food and Beverage Undisputed 01/23/2026 1139860502 CMS
Incyte Corporation $60.00 04/13/2024 Food and Beverage Undisputed 01/23/2026 1141191685 CMS
Incyte Corporation $27.00 04/13/2024 Food and Beverage Undisputed 01/23/2026 1141196675 CMS
Incyte Corporation $58.18 04/13/2024 Food and Beverage Undisputed 01/23/2026 1141197123 CMS
Incyte Corporation $1,320.00 04/18/2024 Consulting Fee Undisputed 01/23/2026 1141197125 CMS
Janssen Biotech, Inc. $17.46 02/16/2024 Food and Beverage Undisputed 01/23/2026 1078747722 CMS
Janssen Biotech, Inc. $15.06 04/15/2024 Food and Beverage Undisputed 01/23/2026 1078748616 CMS
Janssen Biotech, Inc. $14.60 10/01/2024 Food and Beverage Undisputed 01/23/2026 1078748905 CMS
Karyopharm Therapeutics Inc. $18.69 08/05/2024 Food and Beverage Undisputed 01/23/2026 1145540408 CMS
Karyopharm Therapeutics Inc. $19.98 11/06/2024 Food and Beverage Undisputed 01/23/2026 1145540410 CMS
Lilly USA, LLC $21.77 04/03/2024 Food and Beverage Undisputed 01/23/2026 1135752121 CMS
Menarini Silicon Biosystems, Inc. $17.14 12/10/2024 Food and Beverage Undisputed 01/23/2026 1149646818 CMS
Merck Sharp & Dohme LLC $14.52 01/17/2024 Food and Beverage Undisputed 01/23/2026 1141663377 CMS
Merck Sharp & Dohme LLC $24.15 01/26/2024 Food and Beverage Undisputed 01/23/2026 1141663375 CMS
Merck Sharp & Dohme LLC $15.53 07/29/2024 Food and Beverage Undisputed 01/23/2026 1141858854 CMS
Merck Sharp & Dohme LLC $18.42 11/25/2024 Food and Beverage Undisputed 01/23/2026 1141661549 CMS
Mirati Therapeutics, Inc. $19.88 04/26/2024 Food and Beverage Undisputed 01/23/2026 1117172514 CMS
Mirati Therapeutics, Inc. $18.81 07/26/2024 Food and Beverage Undisputed 01/23/2026 1117172506 CMS
Novartis Pharmaceuticals Corporation $14.71 01/05/2024 Food and Beverage Undisputed 01/23/2026 1087164715 CMS
Novartis Pharmaceuticals Corporation $14.18 01/17/2024 Food and Beverage Undisputed 01/23/2026 1087164719 CMS
Novartis Pharmaceuticals Corporation $83.33 01/18/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087164771 CMS
Novartis Pharmaceuticals Corporation $14.27 02/05/2024 Food and Beverage Undisputed 01/23/2026 1087164717 CMS
Novartis Pharmaceuticals Corporation $1.71 02/13/2024 Food and Beverage Undisputed 01/23/2026 1087164721 CMS
Novartis Pharmaceuticals Corporation $11.79 02/15/2024 Food and Beverage Undisputed 01/23/2026 1087164733 CMS
Novartis Pharmaceuticals Corporation $20.14 02/26/2024 Food and Beverage Undisputed 01/23/2026 1087164727 CMS
Novartis Pharmaceuticals Corporation $15.34 02/28/2024 Food and Beverage Undisputed 01/23/2026 1087164723 CMS
Novartis Pharmaceuticals Corporation $12.89 03/27/2024 Food and Beverage Undisputed 01/23/2026 1087164743 CMS
Novartis Pharmaceuticals Corporation $10.34 04/10/2024 Food and Beverage Undisputed 01/23/2026 1087164731 CMS
Novartis Pharmaceuticals Corporation $21.81 06/18/2024 Food and Beverage Undisputed 01/23/2026 1087164755 CMS
Novartis Pharmaceuticals Corporation $20.54 08/16/2024 Food and Beverage Undisputed 01/23/2026 1087164763 CMS
Novartis Pharmaceuticals Corporation $15.12 09/04/2024 Food and Beverage Undisputed 01/23/2026 1087164765 CMS
Novartis Pharmaceuticals Corporation $15.19 09/18/2024 Food and Beverage Undisputed 01/23/2026 1087164775 CMS
Novartis Pharmaceuticals Corporation $14.08 10/02/2024 Food and Beverage Undisputed 01/23/2026 1087164773 CMS
Novartis Pharmaceuticals Corporation $10.21 11/05/2024 Food and Beverage Undisputed 01/23/2026 1087164781 CMS
Novartis Pharmaceuticals Corporation $14.54 11/13/2024 Food and Beverage Undisputed 01/23/2026 1087164783 CMS
PFIZER INC. $16.94 02/09/2024 Food and Beverage Undisputed 01/23/2026 1131192669 CMS
PFIZER INC. $39.27 05/07/2024 Food and Beverage Undisputed 01/23/2026 1131315241 CMS
PFIZER INC. $27.25 08/12/2024 Food and Beverage Undisputed 01/23/2026 1131898095 CMS
PFIZER INC. $26.92 08/21/2024 Food and Beverage Undisputed 01/23/2026 1131346444 CMS
Regeneron Healthcare Solutions, Inc. $20.32 09/27/2024 Food and Beverage Undisputed 01/23/2026 1114352647 CMS
Secura Bio, Inc. $14.79 05/03/2024 Food and Beverage Undisputed 01/23/2026 1133336939 CMS
Stemline Therapeutics Inc. $24.77 01/05/2024 Food and Beverage Undisputed 01/23/2026 1142968993 CMS
Stemline Therapeutics Inc. $25.45 04/12/2024 Food and Beverage Undisputed 01/23/2026 1142968995 CMS
Stemline Therapeutics Inc. $16.31 07/17/2024 Food and Beverage Undisputed 01/23/2026 1142968997 CMS
Stemline Therapeutics Inc. $27.52 11/15/2024 Food and Beverage Undisputed 01/23/2026 1142969001 CMS
Stemline Therapeutics Inc. $440.00 12/03/2024 Consulting Fee Undisputed 01/23/2026 1142968999 CMS
Takeda Pharmaceuticals U.S.A., Inc. $16.67 11/08/2024 Food and Beverage Undisputed 01/23/2026 1144981436 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.